Repligen Q3 revenue $200.7M (+13% YoY); raises FY revenue guidance to $795-$805M

REPLIGEN CORP

2022-Q3 EPS reported $2.39 revenue$614,774,000

Revenue $200.7M, +13% reported, +19% constant currency, +16% organic; base business up 29% YoY.
GAAP EPS $0.71; adjusted EPS $0.77 (vs $0.78 Q3 2021); GAAP gross margin 56.9%.
FY 2022 revenue guidance raised to $795-$805M (from $790-$810M); base business growth raised to 33%-34%.
Adjusted EPS guidance narrowed to $3.15-$3.20 from $3.13-$3.20; operating income guidance lowered to $231-$235M.
Signed 15-year real-time process monitoring deal with DRS Daylight Solutions; extended Purolite affinity ligand agreement to 2032.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

REPLIGEN CORP reported the year 2022 results: revenue $795-$805 million.

Period: the year 2022
Revenue: $795-$805 million
Result: guidance update

Exact text from the filing

YEAR 2022 GUIDANCE: • Total reported revenue is expected to be in the range of $795-$805 million, compared to our previous guidance of $790-$810 million.

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

REPLIGEN CORP reported the third quarter ended September 30, 2022 results: revenue $200.7 million, net income $40.4 million, EPS $0.71 on a fully diluted basis.

Period: the third quarter ended September 30, 2022
Revenue: $200.7 million
Net income: $40.4 million
EPS: $0.71 on a fully diluted basis
Result: reported results

Exact text from the filing

Total revenue as reported for the third quarter of 2022 increased to $200.7 million compared to $178.2 million for the third quarter of 2021, a year-over-year gain of 13%, or 19% at constant currency, and organic growth of 16%.

View on SEC.gov

Browse all earnings releases →

REPLIGEN CORP filing history →

Source: SEC EDGAR

accession 0001193125-22-274508

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.